Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The daily Top 10 COVID papers


  Breast Cancer

  Free Subscription


04.01.2021

2 Am J Clin Oncol
1 Am J Epidemiol
1 Am J Surg
1 Ann Oncol
1 Ann Surg
4 Ann Surg Oncol
3 Breast Cancer
1 Breast Cancer (Dove Med Press)
1 Breast Cancer Res
24 Breast J
1 Cancer
1 Cancer Cell
1 Cancer Chemother Pharmacol
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Lett
1 Cancer Res
4 Clin Breast Cancer
1 Clin Exp Metastasis
3 Eur J Cancer
5 Eur J Surg Oncol
1 Eur Radiol
3 Int J Cancer
1 Int J Oncol
1 Int J Radiat Oncol Biol Phys
1 J Biol Chem
8 J Natl Cancer Inst
1 J Surg Oncol
6 Lancet Oncol
1 N Engl J Med
2 Pathology
4 PLoS One
5 Radiology
1 Radiother Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Clin Oncol

  1. AMIN NP, Kim SM, Lasio G, Zhou J, et al
    Incidental Coronary Artery Calcium on Breast Radiation Therapy Planning Scans Identifies Patients for Cardiac Preventive Therapy.
    Am J Clin Oncol. 2020;43:826-831.
    PubMed         Abstract available

  2. GUTKIN PM, Ganjoo KN, Lohman M, von Eyben R, et al
    Angiosarcoma of the Breast: Management and Outcomes.
    Am J Clin Oncol. 2020;43:820-825.
    PubMed         Abstract available


    Am J Epidemiol

  3. BAURLEY JW, Kjaersgaard A, Zwick ME, Cronin-Fenton DP, et al
    Bayesian Pathway Analysis for Complex Interactions.
    Am J Epidemiol. 2020;189:1610-1622.
    PubMed         Abstract available


    Am J Surg

  4. SAMMAN S, Cornacchi SD, Foster G, Thabane L, et al
    A population-based study of treatment patterns, 10-year recurrence and breast cancer-specific mortality in a cohort of elderly patients with breast cancer.
    Am J Surg. 2020 Dec 25. pii: S0002-9610(20)30807.
    PubMed         Abstract available


    Ann Oncol

  5. MARTIN M, Zielinski C, Ruiz-Borrego M, Carrasco E, et al
    Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial-PEARL.
    Ann Oncol. 2020 Dec 29. pii: S0923-7534(20)43221.
    PubMed         Abstract available


    Ann Surg

  6. KIM HJ, Dominici L, Rosenberg SM, Zheng Y, et al
    Surgical Treatment after Neoadjuvant Systemic Therapy in Young Women with Breast Cancer: Results from a Prospective Cohort Study.
    Ann Surg. 2020;Publish Ahead of Print.
    PubMed         Abstract available


    Ann Surg Oncol

  7. SALMINEN SH, Wiklund T, Sampo MM, Tarkkanen M, et al
    Treatment and Prognosis of Radiation-Associated Breast Angiosarcoma in a Nationwide Population.
    Ann Surg Oncol. 2020;27:1002-1010.
    PubMed         Abstract available

  8. WOESTE MR, Bhutiani N, Geller AE, Eldridge-Hindy H, et al
    Identifying Factors Predicting Prolonged Opioid Use After Mastectomy.
    Ann Surg Oncol. 2020;27:993-1001.
    PubMed         Abstract available

  9. RAO R, Jackson RS, Rosen B, Brenin D, et al
    Pain Control in Breast Surgery: Survey of Current Practice and Recommendations for Optimizing Management-American Society of Breast Surgeons Opioid/Pain Control Workgroup.
    Ann Surg Oncol. 2020;27:985-990.
    PubMed         Abstract available

  10. PEPARINI N
    Beyond T, N, and M: Impact of Axillary Extranodal Tumor Deposits on the Treatment of Breast Cancer.
    Ann Surg Oncol. 2021 Jan 1. pii: 10.1245/s10434-020-09483.
    PubMed        


    Breast Cancer

  11. SHAFEI MA, Flemban A, Daly C, Kendrick P, et al
    Differential expression of the BCAT isoforms between breast cancer subtypes.
    Breast Cancer. 2020 Dec 24. pii: 10.1007/s12282-020-01197.
    PubMed         Abstract available

  12. CHEN J, Zhang X, Lu Y, Zhang T, et al
    Optimal duration of endocrine therapy with extended aromatase inhibitors for postmenopausal patients with hormone receptor-positive breast cancer: a meta-analysis.
    Breast Cancer. 2021 Jan 2. pii: 10.1007/s12282-020-01196.
    PubMed         Abstract available

  13. WANG H, Zhang S, Yee D, Basu S, et al
    Impact of body mass index on pathological complete response following neoadjuvant chemotherapy in operable breast cancer: a meta-analysis.
    Breast Cancer. 2021 Jan 2. pii: 10.1007/s12282-020-01194.
    PubMed         Abstract available


    Breast Cancer (Dove Med Press)

  14. KUMIE G, Melak T, Wondifraw Baynes H
    The Association of Serum Lipid Levels with Breast Cancer Risks Among Women with Breast Cancer at Felege Hiwot Comprehensive Specialized Hospital, Northwest Ethiopia.
    Breast Cancer (Dove Med Press). 2020;12:279-287.
    PubMed         Abstract available


    Breast Cancer Res

  15. LUNDGREN C, Bendahl PO, Ekholm M, Ferno M, et al
    Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up.
    Breast Cancer Res. 2020;22:140.
    PubMed         Abstract available


    Breast J

  16. ABDEL HADI M, Al Muhanna A, Alratroot J, Shawarby MA, et al
    Angiocentric invasive ductal carcinoma: Breast images.
    Breast J. 2020;26:295-296.
    PubMed        

  17. MOSER T, Creed M, Walker R, Meier G, et al
    Radiotherapy tattoos: Women's skin as a carrier of personal memory-What do we cause by tattooing our patients?
    Breast J. 2020;26:316-318.
    PubMed        

  18. DUBOIS C, Nika E, Hoffmann P, Delouche A, et al
    Solitary fibrous tumor of the breast: A rare entity.
    Breast J. 2020;26:289-290.
    PubMed        

  19. TRIHIA HJ, Valavanis C, Novkovic N, Koutsodontis G, et al
    Polymorphous adenocarcinoma of the breast-an exceptionally rare entity: Clinicopathological description of a case and brief review.
    Breast J. 2020;26:261-264.
    PubMed        

  20. COX J, Sharma N
    Mammography volumes and performance of screen readers: Is it time for international consensus?
    Breast J. 2020;26:331-332.
    PubMed        

  21. OTANI T, Hamada M, Hashimoto Y, Higashi C, et al
    Phyllodes tumor with extensive intraductal spread radiologically mimicking ductal carcinoma in situ.
    Breast J. 2020;26:269-270.
    PubMed        

  22. HAYNES HR, Rose DSC
    Synchronous small lymphocytic lymphoma and metastatic breast carcinoma in axillary lymph nodes: Preservation of follicular architecture only in the portions of affected lymph nodes involved by metastatic carcinoma.
    Breast J. 2020;26:245-246.
    PubMed         Abstract available

  23. GULDE A, Hasanov E, Krug K, Krucke GW, et al
    Everolimus-induced pneumonitis: A diagnostic challenge.
    Breast J. 2020;26:287-288.
    PubMed        

  24. LIM DW, Narod SA
    Outcomes of breast reconstruction following prophylactic bilateral mastectomy.
    Breast J. 2020;26:1637-1638.
    PubMed        

  25. PERISTERI DV, Harissis HV
    Axillary lymph node dissection vs sentinel biopsy only among women with early-stage breast cancer and sentinel node metastasis: A systematic review and meta-analysis.
    Breast J. 2020 Dec 23. doi: 10.1111/tbj.14140.
    PubMed         Abstract available

  26. IDE Y, Liu L, Miura S, Inuzuka M, et al
    Frequency of high-risk hormone receptor-positive breast cancer patients was much higher in Japanese breast cancer patients with germline BRCA1/2 mutations than in sporadic breast cancer patients.
    Breast J. 2020 Dec 30. doi: 10.1111/tbj.14150.
    PubMed        

  27. GANESH KUMAR N, Kung TA
    Guidelines for breast reconstruction during the COVID-19 pandemic: Are we considering enough evidence?
    Breast J. 2020;26:2108-2109.
    PubMed        

  28. MORENO G, Jorns JM
    Endosalpingiosis and other benign epithelial inclusions in breast sentinel lymph nodes.
    Breast J. 2020;26:274-275.
    PubMed        

  29. PUNGLIA RS, Ortiz Pimentel S, Cronin AM, Frank ES, et al
    Patient-preferred outcomes measurement after post-mastectomy radiation therapy and immediate reconstruction.
    Breast J. 2020;26:319-321.
    PubMed        

  30. KAUR G, Mitra S, Singh G, Bal A, et al
    Neuroendocrine carcinoma of the breast arising in malignant phyllodes tumor.
    Breast J. 2020;26:276-277.
    PubMed        

  31. PAPAS Y, Asmar AE, Ghandour F, Hajj I, et al
    Malignant phyllodes tumors of the breast: A comprehensive literature review.
    Breast J. 2020;26:240-244.
    PubMed         Abstract available

  32. DE FARIA LL, Brasil ST, Endo E, Chala L, et al
    Breast fibroadenoma in transgender woman.
    Breast J. 2020;26:293-294.
    PubMed        

  33. BARAJAS D
    Glomus tumor of the male breast.
    Breast J. 2020;26:297-298.
    PubMed        

  34. NIA ES, Leung JWT
    Solitary palpable breast mass as the initial presentation of clinically silent extramedullary acute myeloid leukemia.
    Breast J. 2020;26:267-268.
    PubMed        

  35. BICCHIERAI G, Nori J, De Benedetto D, Boeri C, et al
    Follow-up of B3 breast lesions without residual microcalcifications post vacuum-assisted biopsy, can contrast-enhanced digital mammography help?
    Breast J. 2020;26:299-302.
    PubMed        

  36. GARREFFA E, Cantagalli F, Mastrantuono A, Cammarota E, et al
    Pectoral nerves blocks (PECS) and sedation: A way to avoid general anesthesia in breast surgery - A single institution early experience.
    Breast J. 2020;26:303-305.
    PubMed        

  37. GARDANI M, Bellini E, Villani G, Orsi N, et al
    Breast implant-associated anaplastic large cell lymphoma: A rare case report of lymphoma in the form of a pericapsular solid formation.
    Breast J. 2020;26:247-251.
    PubMed         Abstract available

  38. KIM JM, Jung EJ, Kim JY, Lee HS, et al
    A rare case of mixed type liposarcoma of breast arising in malignant phyllodes tumor.
    Breast J. 2020;26:271-273.
    PubMed        

  39. MEYNARD L, Grellety T
    CDK 4/6 inhibitor successful rechallenge after limiting hepatic toxicity.
    Breast J. 2020;26:255-257.
    PubMed         Abstract available


    Cancer

  40. KNAPP GC, Tansley G, Olasehinde O, Wuraola F, et al
    Geospatial access predicts cancer stage at presentation and outcomes for patients with breast cancer in southwest Nigeria: A population-based study.
    Cancer. 2020 Dec 28. doi: 10.1002/cncr.33394.
    PubMed         Abstract available


    Cancer Cell

  41. BAGATI A, Kumar S, Jiang P, Pyrdol J, et al
    Integrin alphavbeta6-TGFbeta-SOX4 Pathway Drives Immune Evasion in Triple-Negative Breast Cancer.
    Cancer Cell. 2020 Dec 22. pii: S1535-6108(20)30608.
    PubMed         Abstract available


    Cancer Chemother Pharmacol

  42. LUNAR N, Etienne-Grimaldi MC, Macaire P, Thomas F, et al
    Population pharmacokinetic and pharmacodynamic modeling of capecitabine and its metabolites in breast cancer patients.
    Cancer Chemother Pharmacol. 2021 Jan 2. pii: 10.1007/s00280-020-04208.
    PubMed         Abstract available


    Cancer Epidemiol Biomarkers Prev

  43. JOHN EM, McGuire V, Kurian AW, Koo J, et al
    Racial/ethnic disparities in survival after breast cancer diagnosis by estrogen and progesterone receptor status: A pooled analysis.
    Cancer Epidemiol Biomarkers Prev. 2020 Dec 18. pii: 1055-9965.EPI-20-1291.
    PubMed         Abstract available


    Cancer Lett

  44. ZHANG T, Wu B, Akakuru OU, Yao C, et al
    Hsp90 inhibitor-loaded IR780 micelles for mitochondria-targeted mild-temperature photothermal therapy in xenograft models of human breast cancer.
    Cancer Lett. 2020;500:41-50.
    PubMed         Abstract available


    Cancer Res

  45. IRURZUN-ARANA I, McDonald TO, Troconiz IF, Michor F, et al
    Pharmacokinetic Profiles Determine Optimal Combination Treatment Schedules in Computational Models of Drug Resistance.
    Cancer Res. 2020;80:3372-3382.
    PubMed         Abstract available


    Clin Breast Cancer

  46. CALI DAYLAN AE, Leone JP
    Targeted Therapies for Breast Cancer Brain Metastases.
    Clin Breast Cancer. 2020 Dec 1. pii: S1526-8209(20)30323.
    PubMed         Abstract available

  47. SATO J, Azuma K, Kinowaki K, Ikeda K, et al
    Combined Use of Immunoreactivities of RIG-I with Efp/TRIM25 for Predicting Prognosis of Patients With Estrogen Receptor-positive Breast Cancer.
    Clin Breast Cancer. 2020 Dec 9. pii: S1526-8209(20)30328.
    PubMed         Abstract available

  48. SANNA G, Pestrin M, Moretti E, Biagioni C, et al
    A Dose-finding Study of Metronomic Oral Vinorelbine in Combination With Oral Cyclophosphamide and Bevacizumab in Patients With Advanced Breast Cancer.
    Clin Breast Cancer. 2020 Nov 19. pii: S1526-8209(20)30294.
    PubMed         Abstract available

  49. AMMAD UD DIN M, Jamshed S, Patel M
    Use of Immune Checkpoint Inhibitors in Early Triple-Negative Breast Cancer: Beyond the Early Conflicting Results.
    Clin Breast Cancer. 2020 Dec 1. pii: S1526-8209(20)30325.
    PubMed        


    Clin Exp Metastasis

  50. DE A, Beligala DH, Sharma VP, Burgos CA, et al
    Cancer stem cell generation during epithelial-mesenchymal transition is temporally gated by intrinsic circadian clocks.
    Clin Exp Metastasis. 2020;37:617-635.
    PubMed         Abstract available


    Eur J Cancer

  51. RIBELLES N, Jerez JM, Rodriguez-Brazzarola P, Jimenez B, et al
    Machine learning and natural language processing (NLP) approach to predict early progression to first-line treatment in real-world hormone receptor-positive (HR+)/HER2-negative advanced breast cancer patients.
    Eur J Cancer. 2020;144:224-231.
    PubMed         Abstract available

  52. LAKSHMI S, Hughes TA, Priya S
    Exosomes and exosomal RNAs in breast cancer: A status update.
    Eur J Cancer. 2020;144:252-268.
    PubMed         Abstract available

  53. BATTISTI NML, Reed MWR, Herbert E, Morgan JL, et al
    Bridging the Age Gap in breast cancer: Impact of chemotherapy on quality of life in older women with early breast cancer.
    Eur J Cancer. 2020;144:269-280.
    PubMed         Abstract available


    Eur J Surg Oncol

  54. LESNIAK DM, Millochau J, Wang KC, Atlan M, et al
    Breast-conserving therapy can be offered to women with prior breast augmentation.
    Eur J Surg Oncol. 2020;46:1456-1462.
    PubMed         Abstract available

  55. SANDERINK WBG, Caballo M, Strobbe LJA, Bult P, et al
    Reliability of MRI tumor size measurements for minimal invasive treatment selection in small breast cancers.
    Eur J Surg Oncol. 2020;46:1463-1470.
    PubMed         Abstract available

  56. WALSTRA CJEF, Schipper RJ, Poodt IGM, Maaskant-Braat AJG, et al
    Multifocality in ipsilateral breast tumor recurrence - A study in ablative specimens.
    Eur J Surg Oncol. 2020;46:1471-1476.
    PubMed         Abstract available

  57. THILL M, Faridi A, Meire A, Gerber-Schafer C, et al
    Patient reported outcome and cosmetic evaluation following implant-based breast-reconstruction with a titanized polypropylene mesh (TiLOOP(R) Bra): A prospective clinical study in 269 patients.
    Eur J Surg Oncol. 2020;46:1484-1490.
    PubMed         Abstract available

  58. PONZONE R
    Is breast conserving therapy better than mastectomy? Surgeons must speak out.
    Eur J Surg Oncol. 2020;46:1551-1553.
    PubMed         Abstract available


    Eur Radiol

  59. YOON B, Chae EY, Cha JH, Shin HJ, et al
    Male patients with unilateral breast symptoms: an optimal imaging approach.
    Eur Radiol. 2020;30:4242-4250.
    PubMed         Abstract available


    Int J Cancer

  60. KIM S, Park B
    Association between changes in mammographic density category and the risk of breast cancer: A nationwide cohort study in East-Asian women.
    Int J Cancer. 2020 Dec 23. doi: 10.1002/ijc.33455.
    PubMed         Abstract available

  61. LONJOU C, Eon-Marchais S, Truong T, Dondon MG, et al
    Gene and pathway level analyses of iCOGS variants highlight novel signalling pathways underlying familial breast cancer susceptibility.
    Int J Cancer. 2020 Dec 24. doi: 10.1002/ijc.33457.
    PubMed         Abstract available

  62. MITRA D, Vega-Rubin-de-Celis S, Royla N, Bernhardt S, et al
    Abrogating GPT2 in triple negative breast cancer inhibits tumor growth and promotes autophagy.
    Int J Cancer. 2020 Dec 24. doi: 10.1002/ijc.33456.
    PubMed         Abstract available


    Int J Oncol

  63. JIA H, Wu D, Zhang Z, Li S, et al
    Regulatory effect of the MAFGAS1/miR1505p/MYB axis on the proliferation and migration of breast cancer cells.
    Int J Oncol. 2020 Nov 20. doi: 10.3892/ijo.2020.5150.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  64. BILLENA C, Wilgucki M, Flynn J, Modlin L, et al
    10-Year Breast Cancer Outcomes in Women
    Int J Radiat Oncol Biol Phys. 2020 Oct 24. pii: S0360-3016(20)34437.
    PubMed         Abstract available


    J Biol Chem

  65. JARDIN I, Diez-Bello R, Falcon D, Alvarado S, et al
    Melatonin downregulates TRPC6, impairing store-operated calcium entry in triple negative breast cancer cells.
    J Biol Chem. 2020 Dec 30. pii: RA120.015769. doi: 10.1074/jbc.RA120.015769.
    PubMed         Abstract available


    J Natl Cancer Inst

  66. HOUGHTON SC, Eliassen H, Tamimi RM, Willett WC, et al
    Central adiposity and subsequent risk of breast cancer by menopause status.
    J Natl Cancer Inst. 2020 Dec 26. pii: 6050830. doi: 10.1093.
    PubMed         Abstract available

  67. LOHMANN AE, Goodwin PJ
    Obesity and Breast Cancer: Expanding the Hypothesis Space.
    J Natl Cancer Inst. 2020 Jul 6. pii: 5867915. doi: 10.1093.
    PubMed        

  68. ALABOUSI M, Wadera A, Kashif Al-Ghita M, Al-Ghetaa RK, et al
    Performance of Digital Breast Tomosynthesis, Synthetic Mammography and Digital Mammography in Breast Cancer Screening: A Systematic Review and Meta-Analysis.
    J Natl Cancer Inst. 2020 Dec 29. pii: 6054799. doi: 10.1093.
    PubMed         Abstract available

  69. BORDE J, Ernst C, Wappenschmidt B, Niederacher D, et al
    Performance of breast cancer polygenic risk scores in 760 female CHEK2 germline mutation carriers.
    J Natl Cancer Inst. 2020 Dec 29. pii: 6054801. doi: 10.1093.
    PubMed         Abstract available

  70. ELMORE JG, Lee CI
    Keeping Pace with Technology Advances in Breast Cancer Screening: Synthetic 2D Images Outperform Digital Mammography.
    J Natl Cancer Inst. 2020 Dec 29. pii: 6054798. doi: 10.1093.
    PubMed        

  71. REIS-FILHO JS, Davidson NE
    Ki67 Assessment in Breast Cancer: Are We There yet?
    J Natl Cancer Inst. 2020 Dec 28. pii: 6053793. doi: 10.1093.
    PubMed        

  72. NIELSEN TO, Leung SCY, Rimm DL, Dodson A, et al
    Assessment of Ki67 in Breast Cancer: Updated Recommendations from the International Ki67 in Breast Cancer Working Group.
    J Natl Cancer Inst. 2020 Dec 28. pii: 6053794. doi: 10.1093.
    PubMed         Abstract available

  73. RAKOVITCH E, Sutradhar R, Nofech-Mozes S, Gu S, et al
    21-Gene Assay and Breast Cancer Mortality in Ductal Carcinoma in Situ.
    J Natl Cancer Inst. 2020 Dec 28. pii: 6053792. doi: 10.1093.
    PubMed         Abstract available


    J Surg Oncol

  74. ROBERTS A, Baxter NN, Sutradhar R, Lau C, et al
    Reoperation cascade in postmastectomy breast reconstruction and its associated factors: Results from a long-term population-based study.
    J Surg Oncol. 2020;122:1300-1306.
    PubMed         Abstract available


    Lancet Oncol

  75. MORGAN AJ, Giannoudis A, Palmieri C
    The genomic landscape of breast cancer brain metastases: a systematic review.
    Lancet Oncol. 2021;22:e7-e17.
    PubMed         Abstract available

  76. DENT R, Rugo HS
    Most neoadjuvant chemotherapy for triple-negative breast cancer should include platinum.
    Lancet Oncol. 2021;22:27-28.
    PubMed        

  77. TAN AR, Im SA, Mattar A, Colomer R, et al
    Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study.
    Lancet Oncol. 2021;22:85-97.
    PubMed         Abstract available

  78. BARTSCH R, Minichsdorfer C, Kolberg-Liedtke C
    Results from the FeDeriCa trial: are we reducing the burden of breast cancer treatment?
    Lancet Oncol. 2021;22:5-6.
    PubMed        

  79. TOI M, Imoto S, Ishida T, Ito Y, et al
    Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial.
    Lancet Oncol. 2021;22:74-84.
    PubMed         Abstract available

  80. DUBSKY P, Pinker K, Cardoso F, Montagna G, et al
    Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox.
    Lancet Oncol. 2021;22:e18-e28.
    PubMed         Abstract available


    N Engl J Med

  81. BURSTEIN HJ
    Systemic Therapy for Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
    N Engl J Med. 2020;383:2557-2570.
    PubMed        


    Pathology

  82. RAZVI H, Tsang JY, Tse GM
    Re: INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer: author reply.
    Pathology. 2020 Dec 28. pii: S0031-3025(20)31010.
    PubMed        

  83. KAWASAKI T, Kaira K, Nakamura Y, Imai H, et al
    Re: INSM1 is a novel prognostic neuroedocrine marker for luminal B breast cancer.
    Pathology. 2020 Dec 29. pii: S0031-3025(20)31009.
    PubMed        


    PLoS One

  84. WANG L, Wang W, Zeng S, Zheng H, et al
    Construction and validation of a 6-gene nomogram discriminating lung metastasis risk of breast cancer patients.
    PLoS One. 2020;15:e0244693.
    PubMed         Abstract available

  85. MEKONNEN BD
    Breast self-examination practice and associated factors among female healthcare workers in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0241961.
    PubMed         Abstract available

  86. MOODLEY J, Williams P, Gohla G, Major P, et al
    Variation in breast cancer grading in 1,636 resections assessed using control charts and in silico kappa.
    PLoS One. 2020;15:e0242656.
    PubMed         Abstract available

  87. ZABALLA O, Perez A, Gomez Inhiesto E, Acaiturri Ayesta T, et al
    Identifying common treatments from Electronic Health Records with missing information. An application to breast cancer.
    PLoS One. 2020;15:e0244004.
    PubMed         Abstract available


    Radiology

  88. MOSHINA N, Aase HS, Danielsen AS, Haldorsen IS, et al
    Comparing Screening Outcomes for Digital Breast Tomosynthesis and Digital Mammography by Automated Breast Density in a Randomized Controlled Trial: Results from the To-Be Trial.
    Radiology. 2020 Sep 15:201150. doi: 10.1148/radiol.2020201150.
    PubMed         Abstract available

  89. HOOLEY R, Butler R
    Digital Breast Tomosynthesis May Not Provide Optimal Surveillance of Breast Cancer Survivors.
    Radiology. 2020 Dec 22:204219. doi: 10.1148/radiol.2020204219.
    PubMed        

  90. PUJARA AC, Joe AI, Patterson SK, Neal CH, et al
    Digital Breast Tomosynthesis Slab Thickness: Impact on Reader Performance and Interpretation Time.
    Radiology. 2020;297:534-542.
    PubMed         Abstract available

  91. MCKAY JA, Church AL, Rubin N, Emory TH, et al
    A Comparison of Methods for High-Spatial-Resolution Diffusion-weighted Imaging in Breast MRI.
    Radiology. 2020 Aug 25:200221. doi: 10.1148/radiol.2020200221.
    PubMed         Abstract available

  92. CHUNG M, Hayward JH, Woodard GA, Knobel A, et al
    US as the Primary Imaging Modality in the Evaluation of Palpable Breast Masses in Breastfeeding Women, Including Those of Advanced Maternal Age.
    Radiology. 2020 Sep 1:201036. doi: 10.1148/radiol.2020201036.
    PubMed         Abstract available


    Radiother Oncol

  93. BOERSMA LJ, Murrer LHP
    Three large trials on radiotherapy for early breast cancer: what did we learn?
    Radiother Oncol. 2020 Dec 22. pii: S0167-8140(20)31244.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: